These findings highlight a previously unrecognized glucose/NSUN2/TREX2 axis that links nutrient sensing to epitranscriptomic regulation and immune evasion, suggesting that targeting this pathway could simultaneously inhibit tumor growth and sensitize immunologically “cold” tumors to checkpoint blockade (80). This evidence concerns the gene TREX2 and neoplasm.